Posted March 12, 2021
The agency trashes a cheap, off-patent drug for COVID-19, clearing the way for a new blockbuster drug. Action Alert! The FDA recently issued a statement warning patients not to use the drug ivermectin, an off-patent drug for river blindness, to treat COVID-19, despite substantial evidence of its efficacy. The very next day, Merck announced positive results from a clinical trial on a new drug called molnupiravir in eliminating the virus in infected patients. Read more.